Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| BridgeBio Pharma, Inc. | 30,523 | reported | 06 Nov 2025 | tx 13+411,077−133,807 |
| MOORE WALLACE INC | 0 | reported | 27 Feb 2004 | tx 4−16,152 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 06 Nov 2025 | SALE | BridgeBio Pharma, Inc. | 61,031 | 63.72 USD | |
| 06 Nov 2025 | EXERCISE | BridgeBio Pharma, Inc. | 61,031 | 34.65 USD | |
| 06 Nov 2025 | EXERCISE | BridgeBio Pharma, Inc. | 61,031 | 0.00 USD | deriv |
| 20 Jun 2025 | GRANT_AWARD | BridgeBio Pharma, Inc. | 6,589 | 0.00 USD | |
| 20 Jun 2025 | GRANT_AWARD | BridgeBio Pharma, Inc. | 8,425 | 0.00 USD | deriv |
| 21 Jun 2024 | GRANT_AWARD | BridgeBio Pharma, Inc. | 26,014 | 0.00 USD | deriv |
| 21 Jun 2023 | GRANT_AWARD | BridgeBio Pharma, Inc. | 51,501 | 0.00 USD | deriv |
| 22 Jun 2022 | GRANT_AWARD | BridgeBio Pharma, Inc. | 104,921 | 0.00 USD | deriv |
| 30 Dec 2021 | PURCHASE | BridgeBio Pharma, Inc. | 10,402 | 14.34 USD | |
| 28 Dec 2021 | PURCHASE | BridgeBio Pharma, Inc. | 11,745 | 12.73 USD | |
| 28 Dec 2021 | SALE | BridgeBio Pharma, Inc. | 11,745 | 12.80 USD | |
| 17 Jun 2021 | GRANT_AWARD | BridgeBio Pharma, Inc. | 38,895 | 0.00 USD | deriv |
| 12 Feb 2020 | GRANT_AWARD | BridgeBio Pharma, Inc. | 91,554 | 0.00 USD | deriv |
| 27 Feb 2004 | OTHER | MOORE WALLACE INC | 3,525 | — | |
| 27 Feb 2004 | OTHER | MOORE WALLACE INC | 3,750 | — | deriv |
| 27 Feb 2004 | OTHER | MOORE WALLACE INC | 5,000 | — | deriv |
| 27 Feb 2004 | OTHER | MOORE WALLACE INC | 3,877 | — | deriv |